An IIT is a clinical study designed and managed independently of Viatris. The Principal Investigator (PI) assumes full responsibility for the design, ethics and conduct as well as reporting of the study. Viatris may support IIT initiatives by providing funding, drug product or a combination of both.
Please register on the portal and follow the instructions to submit an initial concept. The concept will be vetted by a cross-functional Viatris team. Following review, a full submission may be requested which can be submitted via this portal. A second cross-functional review will take place, following which a communication will be provided by the Committee regarding the review decision and applicable next steps. For assistance in completing the registration, initial concept, or full submission please contact Support@Steeprockinc.com.
Please see the therapeutic areas supported by Viatris below.
Cardiovascular and Metabolic
Immunology & Inflammation
Non-TA-related (North America, Europe, Japan, Australia, New Zealand)
Non-TA-related (China, Taiwan, Hong Kong)